Delcath Systems (STU:DV3R) 3-Year Revenue Growth Rate : 38.00% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Delcath Systems 3-Year Revenue Growth Rate?

Delcath Systems's Revenue per Share for the three months ended in Dec. 2024 was €0.45.

During the past 12 months, Delcath Systems's average Revenue per Share Growth Rate was 927.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 38.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was -50.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Delcath Systems was 38.00% per year. The lowest was -86.00% per year. And the median was -60.80% per year.

Competitive Comparison of Delcath Systems's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Delcath Systems's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Delcath Systems's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Delcath Systems 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Delcath Systems (STU:DV3R) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Delcath Systems 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Delcath Systems's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

DCTH:USA DV3R:Germany

Address

566 Queensbury Avenue, Queensbury, NY, USA, 12804

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems Headlines

No Headlines